Two studies have looked into whether private certifications improve food safety with results varying by certification ...
AI can now create genome viruses in laboratories and redesign toxins to evade controls, raising biosafety alert and rise of ...
“The positive response to Plaza’s probiotic Cecabiotics has been very rewarding,” observed Randy Velarde, President of Plaza. “Working with Intralytix, a world leader in bacteriophage, to provide a ...
T.J. Thomson receives funding from the Australian Research Council. He is an affiliate with the ARC Centre of Excellence for Automated Decision Making & Society. Aaron J. Snoswell receives research ...
LOS ANGELES, Nov. 10, 2025 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity, ...
Let's face it—bats get a bad rap. Their links to disease outbreaks and their spooky association with vampires influence their notoriety. In reality, bats are truly remarkable. Bats support our ...
This is a human-written story voiced by AI. Got feedback? Take our survey. (See our AI policy here.) Artificial intelligence can dash off more than routine emails. It has now written tiny working ...
Innovative alternatives and novel technologies are transforming the way producers prevent and control broiler and turkey diseases. Targeted viruses known as bacteriophages could provide the poultry ...
Bacteriophages, or phages for short, are viruses that infect bacteria. Using phages therapeutically could be very useful in fighting antibiotic-resistant pathogens, but the molecular interactions ...
LOS ANGELES, Sept. 8, 2025 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results